Growing community of inventors

Helsinki, Finland

Marko Uutela

Average Co-Inventor Count = 4.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 28

Marko UutelaKari Alitalo (5 patents)Marko UutelaUlf Eriksson (5 patents)Marko UutelaCarl-Henrik Heldin (2 patents)Marko UutelaKarin Aase (2 patents)Marko UutelaAnnica Ponten (2 patents)Marko UutelaArne Oestman (2 patents)Marko UutelaXuri Li (1 patent)Marko UutelaXuri Lee (1 patent)Marko UutelaMarko Uutela (5 patents)Kari AlitaloKari Alitalo (72 patents)Ulf ErikssonUlf Eriksson (43 patents)Carl-Henrik HeldinCarl-Henrik Heldin (40 patents)Karin AaseKarin Aase (5 patents)Annica PontenAnnica Ponten (3 patents)Arne OestmanArne Oestman (2 patents)Xuri LiXuri Li (5 patents)Xuri LeeXuri Lee (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ludwig Institute for Cancer Research Limited (4 from 525 patents)

2. Licentia, Ltd. (2 from 20 patents)

3. Other (1 from 832,843 patents)

4. Helsinki University Licensing, Ltd. (1 from 15 patents)


5 patents:

1. 7476654 - Method for modulating, regulating and/or stabilizing angiogenesis

2. 7408040 - Antibodies to PDGF-D

3. 7148037 - Platelet-derived growth factor D, DNA coding therefor, and uses thereof

4. 7105481 - Method for stimulating connective tissue growth or wound healing

5. 6706687 - Platelet-derived growth factor D

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…